Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery

Hypertension

Volumn 42, Issue 4 I, 2003, Pages 562-568

  Büssemaker, Eckhart ^b   Popp, Rüdiger ^b   Fisslthaler, Beate ^b   Larson, Christiana M ^b   Fleming, Ingrid ^b   Busse, Rudi ^b   Brandes, Ralf P ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

Acetylcholine; Animal models of hypertension; Endothelium; Endothelium derived factors; Nitric oxide; Renal artery

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ACTIVATED POTASSIUM CHANNEL; DICLOFENAC; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) NITROARGININE; NITRIC OXIDE; SULFAPHENAZOLE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MUSCLE FIBER MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ACETYLCHOLINE; AGE FACTORS; ANIMALS; BIOLOGICAL FACTORS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HYPERTENSION; MEMBRANE POTENTIALS; NA(+)-K(+)-EXCHANGING ATPASE; ORGAN CULTURE TECHNIQUES; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENAL ARTERY; SULFAPHENAZOLE; VASODILATOR AGENTS;

EID: 0141893558     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000088852.28814.E2     Document Type: Article

References (44)

1. Bassenge E. Control of coronary blood flow by autacoids. Basic Res Cardiol. 1995;90:125-141.
2. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
3. Lüscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertens Suppl. 1994;12:S105-S116.
4. Kahonen M, Tolvanen JP, Kalliovalkama J, Wu X, Karjala K, Makynen H, Porsti I. Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats. Eur J Pharmacol. 1999;368:213-222.
5. Onaka U, Fujii K, Abe I, Fujishima M. Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats. Circulation. 1998;98: 175-182.
6. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996;97:1916-1923.
7. Kojda G, Harrison DG. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Research. 1999;43:562-571.
8. Kaw S, Hecker M. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:133-139.
9. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23: 374-380.
10. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396:269-216.
11. Knot HJ, Zimmermann PA, Nelson MT. Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. J Physiol (London). 1996;492: 419-430.
12. Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol (London). 1998;508:561-573.
13. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
14. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA. 2000;97: 9747-9752.
15. Brandes RP, Behra A, Lebherz C, Böger RH, Bode-Böger SM, Mügge A. Nωnitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis. 1997;135:49-55.
16. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996;94:3341-3347.
17. Büssemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, Brandes RP. Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovasc Res. 2003;59:181-188.
18. Chaytor AT, Martin PE, Edwards DH, Griffith TM. Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. Am J Physiol. 2001;280:H2441-H2450.
19. Sandow SL, Bramich NJ, Bandi HP, Rummery NM, Hill CE. Structure, function, and endothelium-derived hyperpolarizing factor in the caudal artery of the SHR and WKY rat. Arterioscler Thromb Vasc Biol. 2003; 23:822-828.
20. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44-51.
21. Vanheel B, Calders P, Van dB, I, Van d, V. Influence of some phospholipase A2 and cytochrome P450 inhibitors on rat arterial smooth muscle K+ currents. Can J Physiol Pharmacol. 1999;77:481-489.
22. Hernandez-Benito MJ, Macianskiene R, Sipido KR, Flameng W, Mubagwa K. Suppression of transient outward potassium currents in mouse ventricular myocytes by imidazole antimycotics and by glybenclamide. J Pharmacol Exp Ther. 2001;298:598-606.
23. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, Fujishima M. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992;70:660-669.
24. Fujii K, Ohmori S, Tominaga M, Abe I, Takata Y, Ohya Y, Kobayashi K, Fujishima M. Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol. 1993;265:H509-H516.
25. Mantelli L, Amerini S, Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol. 1995; 25:595-602.
26. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.
27. Edwards G, Gardener MJ, Feletou M, Brady G, Vanhoutte PM, Weston AH. Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol. 1999;128:1064-1070.
28. Richards GR, Weston AH, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. Suppression of K(+)-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol. 2001;134:1-5.
29. Weston AH, Richards GR, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. K(+)-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na(+)/K(+)-ATPases. Br J Pharmacol. 2002;136:918-926.
30. Emerson GG, Segal SS. Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: role in vasomotor control. Circ Res. 2000;87:474-479.
31. Spagnoli LG, Villaschi S, Neri L, Palmieri G. Gap junctions in myo-endothelial bridges of rabbit carotid arteries. Experientia. 1982;38: 124-125.
32. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002;90:1108-1113.
33. Edwards G, Feletou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol. 1999;128:1788-1794.
34. Harris D, Martin PE, Evans WH, Kendall DA, Griffith TM, Randall MD. Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K(+)-relaxation. Eur J Pharmacol. 2000; 402:119-128.
35. Zygmunt PM, Edwards G, Weston AH, Davis SC, Högestätt ED. Effects of cytochrome P450- inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br J Pharmacol. 1996;118:1147-1152.
36. Fulton D, McGiff JC, Wolin MS, Kaminski P, Quilley J. Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat. J Pharmacol Exp Ther. 1997;280:702-709.
37. Jiang F, Li CG, Rand MJ. Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries. Br J Pharmacol. 2000;130:1191-1200.
38. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest. 1999;104:751-760.
39. Pomposiello SI, Carroll MA, Falck JR, McGiff JC. Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR. Hypertension. 2001;37:887-893.
40. O'Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys. 1994;310:32-39.
41. Ewart HS, Klip A. Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995;269:C295-C311.
42. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol. 1998;275:F633-F650.
43. Carlsen RC, Gray SD, Pickar JG. Na+, K(+)-pump activity and skeletal muscle contractile deficits in the spontaneously hypertensive rat. Acta Physiol Scand. 1996;156:237-245.
44. Pickar JG, Atrakchi A, Gray SD, Carlsen RC. Apparent upregulation of Na+, K+ pump sites in SHR skeletal muscle with reduced transport capacity. Clin Exp Hypertens A. 1991;13:645-652.